Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

Medtronic’s Endurant AAA Stent Graft Delivers Durable Outcomes for Abdominal Aortic Aneursym Repair

November 19, 2012 3:13 pm | by Medtronic | News | Comments

Chosen for nearly one out of every two endovascular abdominal aortic aneurysm repairs worldwide, the Endurant AAA stent graft system from Medtronic, Inc. continues to show robust results in mid-term follow-up, according to two-year clinical data presented at VEITHsymposium, which concluded yesterday in New York.

Novel Stethoscope Using Solvay's Radel® PPSU is First to Assess Injured in High-Noise Environments

November 8, 2012 12:02 pm | News | Comments

Active Signal Technologies Inc., Linthicum Heights, Md., a leading contract research firm specializing in electromechanical devices, has developed the first stethoscope that can detect heart/lung activity in high ambient noise (above 90 dBA) including combat casualty and civilian emergency medical environments.

Genetically Engineered Tomatoes Decrease Plaque Build-up in Mice

November 5, 2012 12:18 pm | by GLOBE NEWSWIRE | News | Comments

For the first time, genetically engineered tomato plants produced a peptide that mimics the actions of good cholesterol when eaten, researchers reported at the American Heart Association's Scientific Sessions 2012. In the study, mice that ate the freeze-dried, ground tomatoes had less inflammation and reduced atherosclerosis (plaque build-up in the arteries).


Bypass Surgery More Cost Effective Than Stents for Diabetics Long Term

November 5, 2012 12:04 pm | by GLOBE NEWSWIRE | News | Comments

Bypass surgery may be more expensive than drug-coated stents, but in the long run it's more cost effective for patients with diabetes because of superior long-term clinical outcomes, according to late-breaking clinical trial research presented at the American Heart Association's Scientific Sessions 2012.

New Device Could Allow Your Heartbeat to Power Pacemaker

November 5, 2012 11:52 am | by GLOBE NEWSWIRE | News | Comments

An experimental device converted energy from a beating heart to provide enough electricity to power a pacemaker, in a study presented at the American Heart Association's Scientific Sessions 2012. The findings suggest that patients could power their pacemakers -- eliminating the need for replacements when batteries are spent.

Medtronic Engages Cardiologists in ‘World Diabetes Day’

October 24, 2012 11:24 am | by Medtronic | News | Comments

Reinforcing its commitment to people with diabetes, Medtronic, Inc. (NYSE: MDT) is promoting its long-standing partnership with the International Diabetes Federation (IDF) through a new initiative surrounding “World Diabetes Day” on Nov. 14 that aims to engage interventional cardiologists worldwide in raising awareness of the connection between diabetes and coronary artery disease.

Medtronic Stent Successfully Treats Long Lesions and Small Vessels, Two Characteristics Typical of Patients with Diabetes, in Multiple Studies

October 23, 2012 11:44 am | by Medtronic | News | Comments

For the treatment of long lesions and small vessels –– two challenging characteristics of coronary artery disease commonly found in patients with diabetes –– the Resolute drug-eluting stent from Medtronic, Inc. (NYSE: MDT) delivered successful clinical results, according to new data presented at the 24th Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

Vascular Solutions Launches R-Band Radial Hemostasis Device

October 22, 2012 9:48 am | by Globe Newswire | News | Comments

Vascular Solutions, Inc. today announced that it has launched the R-Band radial hemostasis compression device in the United States. Vascular Solutions is the exclusive distributor of the R-Band device in the U.S. under an agreement entered into with Lepu Medical Technology (Beijing) Co., Ltd., the developer and manufacturer of the device.


Implantable devices are not a luxury

October 22, 2012 9:42 am | by European Society of Cardiology | News | Comments

“Implantable devices can save lives and decrease mortality, they are not a luxury” said Professor Angelo Auricchio, President of the European Heart Rhythm Association (EHRA) of the ESC at the ICD for Life Summit which concluded  in Belgrade, Serbia, today. “In the face of the impressive rise in cardiovascular related mortality in Central and Eastern Europe, we need to implement a structured approach...

Balloon-Forming Innovations Improve Quality and Reduce Cost

October 19, 2012 4:17 pm | by David Yanes and Eric Mabry | Interface Catheter Solutions | Articles | Comments

Catheter balloons are an important device for a variety of cardiovascular treatments. However, their manufacture can be a complicated process that, if completed wrong, can lead to waste and excess costs. This article highlights a number of innovative technologies that are being offered to help balloon manufacturers ensure their products are defect-free the first time.

Applying Tech: Cardiovascular, Part II

October 18, 2012 3:27 pm | by John Beigel, Brian McPherson, Robert Hergenrother, Peter Gabriele, and Donald M. Garcia | Meder Electronic Inc., SurModics, Inc., Secant Medical, Inc. , Boyd Coatings Research, Inc. | Articles | Comments

It’s not the journey, it’s the destination. In the case of interventional cardiovascular devices, both the journey and the destination are vital. These devices need to navigate the tortuous pathways of the vasculature in order to access and treat complex distal lesions. Getting there isn’t always easy.

Applying Tech: Cardiovascular, Part I

October 18, 2012 3:12 pm | by Andrew Cannon, Richard M. Rots, Mark Geiger, John Schmitz, and Sascha Weiler | Hoowaki, LLC, Interface Catheter Solutions | Articles | Comments

When a manufacturer picks up a cardiovascular device, they literally hold someone’s life. There is no room for flaws in the quality of this product, or any other in the cardiovascular realm. These devices are shrinking, while becoming increasingly advanced—more intricate parts achieve more complex functions, within a surface area that leaves only enough space for perfection. So the case has never been greater for quality assurance. Conducting risk analysis through variation analysis software can satisfy it.

Medtronic Announces Approval and Launch of Japan’s First MR-Conditional Pacemaker System

October 18, 2012 12:32 pm | by Medtronic | News | Comments

Medtronic, Inc. (NYSE: MDT), today announced the Japanese regulatory approval and launch of the Advisa DR MRI™ SureScan™ pacing system. The Advisa MRI system is the first and only MR-Conditional pacemaker available to patients in Japan, the world’s second largest market for medical devices.


AngioDynamics to Acquire Vortex Medical

October 8, 2012 4:28 pm | by GLOBE NEWSWIRE | News | Comments

AngioDynamics, a leading provider of innovative minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today it has entered into a definitive agreement to acquire all the outstanding capital stock of Vortex Medical Inc., a privately-held company focused on the development of innovative medical devices...

Slovenia's First Total Artificial Heart Patient Receives Heart Transplant

October 8, 2012 3:04 pm | by SynCardia Systems | News | Comments

SynCardia Systems, Inc., manufacturer of  the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that University Medical Center (UMC) Ljubljana has transplanted Slovenia's first patient to receive the SynCardia temporary Total Artificial Heart. The patient, 61-year-old Nikola Gašpic, received a matching donor heart on July 1...

Cook Medical Launches Zilver Vena Venous Self-Expanding Stent in Canada

October 8, 2012 2:48 pm | by Cook Medical | News | Comments

Following Health Canada approval, Cook Medical made the Zilver Vena Venous Self-Expanding Stent available to physicians across Canada at the 2012 Annual Meeting of the Canadian Society for Vascular Surgery. Designed to restore blood flow in obstructed iliofemoral veins, Zilver Vena provides physicians with a tool designed specifically for stenting obstructed iliofemoral veins.

Mediware Receives Updated FDA Clearance for Core Blood Products

October 4, 2012 4:07 pm | by GLOBE NEWSWIRE | News | Comments

Mediware Information Systems, Inc. (Nasdaq:MEDW) announced that the 2012 versions of the company's core blood management software products, including LifeTrak(R) and HCLL(R) Transfusion, have received updated 510(k) clearance by the US FDA. The software systems are used by more than 500 hospital and blood center facilities in the United States, Canada, Ireland, and Singapore...

Analyst Insight: Investors Breathe Sigh of Relief: Boston Scientific Gets First-in-Class FDA Go-Ahead

October 3, 2012 11:17 am | by GlobalData | News | Comments

On September 28, 2012, the US Food and Drug Administration granted the Boston Scientific Corporation (BSX) regulatory approval for its first-in-class subcutaneous implantable defibrillator (S-ICD) system. This S-ICD system establishes the first new category of cardiac rhythm management devices since the introduction of cardiac resynchronization therapy.

Tangent Medical Receives FDA Clearance for the NovaCath Secure IV Catheter System

September 28, 2012 9:05 am | by Tangent Medical | News | Comments

Ann Arbor-based Tangent Medical, an innovator in IV therapy products, recently announced it has received FDA 510(k) clearance for the NovaCath™ Secure IV Catheter System, a product designed to set new standards in peripheral IV catheter design, functionality and performance.

Analyst Insight: Abbott’s Absorb is the New Face of the Stent Industry

September 27, 2012 9:29 am | by GlobalData | News | Comments

The world’s first drug-eluting bioabsorbable vascular scaffold has been launched and will revolutionize the stent industry. On September 25th, 2012, Abbott announced the launch of its drug-eluting bioabsorbable stent, Absorb, in Europe, the Middle East and parts of Asia Pacific and Latin America. Absorb, which received CE mark certification in 2011, is used to treat coronary artery disease.

Merit Medical Receives 510(k) Clearance to Market the Merit Laureate Hydrophilic Guide Wire

September 24, 2012 9:44 am | by GLOBE NEWSWIRE | News | Comments

Merit Medical Systems, Inc. (Nasdaq:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, today announced that it has received 510(k) clearance from the Food and Drug Administration to market the Merit Laureate(R) hydrophilic guide wire.

UL and AAMI to Develop Interoperability Standards

September 18, 2012 3:14 pm | by Underwriters Laboratories | News | Comments

With the goal of improving patient safety and healthcare efficiency, AAMI and UL (Underwriters Laboratories) are joining forces to develop a suite of standards on medical device interoperability-one of the biggest challenges facing the modern healthcare community. The collaboration is a first for AAMI and UL, and comes at a time when many healthcare facilities and manufacturers are grappling...

Maquet Study Results May Invalidate Industry Standard for Treating Cardiogenic Shock

August 30, 2012 3:46 pm | by GlobalData | News | Comments

Primary results from an ongoing trial conducted by Maquet Cardiovascular, a subsidiary of the Swedish Getinge Group, investigating the use of intra-aortic balloon pumps (IABP) as an adjuvant treatment for myocardial infarction (MI) complicated by cardiogenic shock have shown no difference in patient survival compared to standard care alone.

AngioDynamics Earns FDA Clearance for First Vascular Access Product With BioFlo Technology to Reduce Catheter-Related Thrombus

August 30, 2012 2:24 pm | by GLOBE NEWSWIRE | News | Comments

AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the U.S. Food and Drug Administration has granted 510(k) clearance for its BioFlo peripherally inserted central catheters (PICCs) with Endexo technology...

TAVI restricted to very old or very sick patients

August 30, 2012 2:21 pm | by European Society of Cardiology | News | Comments

Cardiologists are restricting the use of transcatheter aortic valve implantation (TAVI) to very old or very sick patients at high surgical risk, according to research presented at the ESC Congress today. The first results of the Transcatheter Valve Treatment (TCVT) Sentinel Pilot Registry were presented by registry chairman Professor Carlo Di Mario.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.